Nasdaq - Delayed Quote
USD
Janus Henderson Global Life Sciences N (JFNNX)
92.88
+2.02
(+2.22%)
As of 8:06:40 AM EDT. Market Open.
Fund Summary
The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.
Janus Henderson Global Life Sciences N
Denver CO 80206
151 Detroit Street
Fund Overview
| Category | Health |
| Fund Family | Janus Henderson |
| Net Assets | 5.8B |
| YTD Return | 7.76% |
| Yield | 0.48% |
| Morningstar Rating | |
| Inception Date | Dec 31, 1998 |
Fund Operations
| Last Dividend | 0.43 |
| Last Cap Gain | 37.00 |
|---|---|
| Holdings Turnover | 30.00% |
| Average for Category | -- |
Fees & Expenses
| Expense | JFNNX | Category Average |
|---|---|---|
|
Annual Report Expense Ratio (net)
|
0.68% | 1.03% |
|
Prospectus Net Expense Ratio
|
0.68% | -- |
|
Prospectus Gross Expense Ratio
|
0.68% | -- |
|
Max 12b1 Fee
|
-- | -- |
|
Max Front End Sales Load
|
-- | 5.37% |
|
Max Deferred Sales Load
|
-- | 1.19% |
|
3 Yr Expense Projection
|
0 | -- |
|
5 Yr Expense Projection
|
0 | -- |
|
10 Yr Expense Projection
|
0 | -- |
Management Information
Morningstar Style Box
